ArticleFrontiers in artificial intelligence2025
BioBricks.ai: a versioned data registry for life sciences data assets.
Article in Frontiers in artificial intelligence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Democratizing Artificial Intelligence in Toxicology: Real-World Applications and Automated Computational Workflows.Chemical research in toxicology · 2026Review
- Building trust in the integration of artificial intelligence into chemical risk assessment: findings from the 2024 ECETOC workshop.Archives of toxicology · 2026Article
- The data substrate of exposome intelligence: an interoperability profile for untargeted metabolomics.Frontiers in artificial intelligence · 2026Article
- AI snake oil? A risk/benefit analysis for toxicology.Frontiers in artificial intelligence · 2026Article
- Green toxicology only becomes beautiful through AI.Frontiers in chemistry · 2026Review
Corrections and comments
- Update of
Authors and funding
15 authors.
Funding
Abstract
Introduction: Researchers in biomedicine and public health often spend weeks locating, cleansing, and integrating data from disparate sources before analysis can begin. This redundancy slows discovery and leads to inconsistent pipelines. Methods: We created BioBricks.ai, an open, centralized repository that packages public biological and chemical datasets as modular "bricks." Each brick is a Data Version Control (DVC) Git repository containing an extract‑transform‑load (ETL) pipeline. A package‑manager-like interface handles installation, dependency resolution, and updates, while data are delivered through a unified backend (https://biobricks.ai). Results: The current release provides >90 curated datasets spanning genomics, proteomics, cheminformatics, and epidemiology. Bricks can be combined programmatically to build composite resources; benchmark use‑cases show that assembling multi‑dataset analytic cohorts is reduced from days to minutes compared with bespoke scripts. Discussion: BioBricks.ai accelerates data access, promotes reproducible workflows, and lowers the barrier for integrating heterogeneous public datasets. By treating data as version‑controlled software, the platform encourages community contributions and reduces redundant engineering effort. Continued expansion of brick coverage and automated provenance tracking will further enhance FAIR (Findable, Accessible, Interoperable, Reusable) data practices across the life‑science community.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.